Ausgabe 5/2010
Inhalt (16 Artikel)
Testing the theory of immune selection in cancers that break the rules of transplantation
Ariberto Fassati, N. Avrion Mitchison
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
Hiroyuki Suzuki, Nobuhito Chikazawa, Takehiko Tasaka, Junji Wada, Akio Yamasaki, Yoshiki Kitaura, Masae Sozaki, Masao Tanaka, Hideya Onishi, Takashi Morisaki, Mitsuo Katano
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
James L. Gulley, Philip M. Arlen, Ravi A. Madan, Kwong-Yok Tsang, Mary P. Pazdur, Lisa Skarupa, Jacquin L. Jones, Diane J. Poole, Jack P. Higgins, James W. Hodge, Vittore Cereda, Matteo Vergati, Seth M. Steinberg, Susan Halabi, Elizabeth Jones, Clara Chen, Howard Parnes, John J. Wright, William L. Dahut, Jeffrey Schlom
Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh
Akio Yamasaki, Chizu Kameda, Rui Xu, Haruo Tanaka, Takehiko Tasaka, Nobuhito Chikazawa, Hiroyuki Suzuki, Takashi Morisaki, Makoto Kubo, Hideya Onishi, Masao Tanaka, Mitsuo Katano
Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting
Matthias May, Sabine Brookman-May, Bernd Hoschke, Christian Gilfrich, Friederike Kendel, Susann Baxmann, Stefan Wittke, Stephan T. Kiessig, Kurt Miller, Manfred Johannsen
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine
Irina Daurkin, Evgeniy Eruslanov, Johannes Vieweg, Sergei Kusmartsev
A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector
Weijun Zhang, Tong Zhang, Mary-Jo Turk, Edward J. Usherwood
Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy
Eftychia Lekka, Angelos D. Gritzapis, Sonia A. Perez, Nikolaos Tsavaris, Ioannis Missitzis, Avgi Mamalaki, Michael Papamichail, Constantin N. Baxevanis
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model
Nasreen Vohra, Monique Verhaegen, Lisa Martin, Amy Mackay, Shari Pilon-Thomas
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin
Robert Sarnovsky, Tara Tendler, Matheusz Makowski, Maureen Kiley, Antonella Antignani, Roberta Traini, Jingli Zhang, Raffit Hassan, David J. FitzGerald
Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2Kb-restricted T cell epitope
Jung-Sun Park, Hye-Sung Kim, Mi-Young Park, Chang-Hyun Kim, Yeun-Jun Chung, Yong-Kil Hong, Tai-Gyu Kim
EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor
Shinjiro Yamaguchi, Tomohide Tatsumi, Tetsuo Takehara, Akira Sasakawa, Masashi Yamamoto, Keisuke Kohga, Takuya Miyagi, Tatsuya Kanto, Naoki Hiramastu, Takami Akagi, Mitsuru Akashi, Norio Hayashi
Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma
Miki Tongu, Nanae Harashima, Takaya Yamada, Takayuki Harada, Mamoru Harada
Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function
Chang-Xuan You, Yong Liu, Min Shi, Maohua Cao, Rong-Cheng Luo, Paul L. Hermonat
Activation of innate immunity to reduce lung metastases in breast cancer
Julie L. Jordan, A. Nowak, T. D. G. Lee
Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3
Cornelia L. Trimble, Shiwen Peng, Christopher Thoburn, Ferdynand Kos, T. C. Wu